Special cardiology faculty & fellows breakfast in honor of Dr. Nicolas Smedira , our distinguished Cardiology Grand Rounds speaker. The breakfast will be located in the Texas Heart Institute Denton A. Cooley Executive Board Room between 9:30 and 11:00 am.
Nicholas G. Smedira, MD, is a staff cardiothoracic surgeon in the Department of Thoracic and Cardiovascular Surgery and former Director of Quality for the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is board-certified in thoracic surgery.
Dr. Smedira earned his undergraduate (Phi Beta Kappa; magna cum laude) and medical (Alpha Omega Alpha; MD with honors) degrees from the University of Rochester School of Medicine and Dentistry, New York. After completing his residency in general surgery at the University of California, San Francisco Medical Center, where he became Chief Surgical Resident. Dr. Smedira received fellowships in cardiothoracic surgery, critical care medicine and research from the University of California, San Francisco Medical Center. He won a postdoctoral National Research Service Award fellowship. He then received a fellowship in cardiothoracic surgery at Cleveland Clinic, where he was appointed in 1995 as a Staff Cardiac Surgeon.
Dr. Smedira was selected as the 2004 Teacher of the Year in Cleveland Clinic’s Department of Cardiovascular and Thoracic Surgery. He was a Visiting Professor at the Ministry of Health in Singapore, the Atlantic Health System in New Jersey, the Ottawa Heart Institute in Canada, and the University of California, San Francisco. Dr. Smedira was appointed to the faculty of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University as a Professor in 2007, and he has served on the editorial board of the Journal of Thoracic and Cardiovascular Surgery.
As principal or co-investigator in more than 100 clinical trials and studies, Dr. Smedira has focused his research efforts on his specialty interests, including the surgical treatment of patients with ischemic heart failure, cellular therapy for advanced heart damage, the use of bivalirudin as an alternative to heparin during cardiac surgery, and rotary blood pumps, such as the HeartWare and HeartMate II devices, which are used to support patients until they receive a transplant (bridge-to-transplant) or for permanent cardiac support (destination therapy).
Dr. Smedira has been invited to speak about his clinical experience and research findings at hundreds of conferences and symposia worldwide. He has written numerous book chapters on subjects related to his specialty interests, including advances in cardiac intensive care, cardiac surgery, assistive devices and treatment of patients with heart failure. He has authored/co-authored hundreds of published studies and abstracts in peer-reviewed publications, including The New England Journal of Medicine, The Journal of the American Medical Association, The Journal of Thoracic and Cardiovascular Surgery, The Annals of Thoracic Surgery, Journal of the American College of Cardiology, and others.